Literature DB >> 9451065

Preconditioning human cardiomyocytes and endothelial cells.

T Shirai1, V Rao, R D Weisel, J S Ikonomidis, R K Li, L C Tumiati, F Merante, D A Mickle.   

Abstract

BACKGROUND: The effects of simulated "ischemia" and "reperfusion" were evaluated in cell cultures of human ventricular cardiomyocytes and human saphenous vein endothelial cells.
METHODS: Myocyte and endothelial cell cultures were exposed to a low volume (1.5 ml) of either hypoxic (oxygen tension = 16 mm Hg) or anoxic (oxygen tension = 0 mm Hg) phosphate-buffered saline solution for 90 minutes ("ischemia") followed by 30 minutes of simulated "reperfusion." Cell injury was evaluated by trypan blue exclusion. Next, the effects of a preconditioning stimulus were evaluated by a brief (10 minute) exposure to hypoxic or anoxic ischemia and 10 minutes of reperfusion before prolonged (90 minutes) anoxic ischemia. Finally, the effects of anoxic preconditioning on intracellular lactate accumulation and extracellular lactate and acid release were assessed.
RESULTS: "Ischemia" and "reperfusion" resulted in greater injury to endothelial cells than to cardiomyocytes. In both cell types, anoxic ischemia resulted in greater injury than hypoxic ischemia. Preconditioning reduced cell injury in myocytes but not in endothelial cells. Endothelial cells produced more lactate than cardiomyocytes under normoxic conditions. Ischemia increased lactate accumulation and release in cardiomyocytes but not endothelial cells. Preconditioning reduced lactate accumulation and release in cardiomyocytes but not endothelial cells.
CONCLUSIONS: Endothelial cells were more susceptible to the same period of simulated ischemia than cardiomyocytes. Preconditioning protected cardiomyocytes but not endothelial cells from a subsequent prolonged period of ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451065     DOI: 10.1016/s0022-5223(98)70459-3

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release.

Authors:  Chuanxi Cai; Lei Teng; Duc Vu; Jia-Qiang He; Yiru Guo; Qianghong Li; Xian-Liang Tang; Gregg Rokosh; Aruni Bhatnagar; Roberto Bolli
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 2.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2008-05-10       Impact factor: 5.000

3.  Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways.

Authors:  Lei Teng; Edward Bennett; Chuanxi Cai
Journal:  J Biol Chem       Date:  2016-03-03       Impact factor: 5.157

4.  Sulfiredoxin-1 enhances cardiac progenitor cell survival against oxidative stress via the upregulation of the ERK/NRF2 signal pathway.

Authors:  Xiuchun Li; Pan He; Xiao-Liang Wang; Shuning Zhang; Neil Devejian; Edward Bennett; Chuanxi Cai
Journal:  Free Radic Biol Med       Date:  2018-05-14       Impact factor: 7.376

Review 5.  Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.

Authors:  Mohammad Mominur Rahman; Mohammad Rezaul Islam; Mohammad Touhidul Islam; Mohammad Harun-Or-Rashid; Mahfuzul Islam; Sabirin Abdullah; Mohammad Borhan Uddin; Sumit Das; Mohammad Saidur Rahaman; Muniruddin Ahmed; Fahad A Alhumaydhi; Talha Bin Emran; Amany Abdel-Rahman Mohamed; Mohammad Rashed Iqbal Faruque; Mayeen Uddin Khandaker; Gomaa Mostafa-Hedeab
Journal:  Biology (Basel)       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.